Overview

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R

Status:
NOT_YET_RECRUITING
Trial end date:
2027-06-01
Target enrollment:
Participant gender:
Summary
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R in Patients with Primary Hypercholesterolemia
Phase:
PHASE3
Details
Lead Sponsor:
Ahn-Gook Pharmaceuticals Co.,Ltd